Stock data

友華 (4120)

友華 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$435.32M, up 10.0% from a year earlier. EPS over the last four quarters totals -NT$6.64.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 友華 in Insightr